Functional Magnetic Resonance Neuroimaging of Drug Dependence: Naloxone-Precipitated Morphine Withdrawal
Authors: Lowe A.S.1; Williams S.C.R.1; Symms M.R.2; Stolerman I.P.3; Shoaib M.3
Source: NeuroImage, Volume 17, Number 2, October 2002 , pp. 902-910(9)
Publisher: Academic Press
Abstract:
This study investigated the potential utility of fMRI as a neuroimaging technique to examine drug dependence using a robust animal model of drug withdrawal. Two groups of rats chronically pretreated with incremental doses of morphine sulfate (2, 7, 15, 30, 40, 50, 50, and 50 mg/kgsubcutaneous injection) were subjected to opioid precipitated withdrawal (using the opioid antagonist, naloxone) and subsequently behaviorally assessed or gradient-echo imaged under urethane anesthesia. Whole brain, group statistical parametric maps revealed statistically significant changes in signal intensity following administration of 1 mg/kg naloxone (corrected for multiple comparisons: P < 0.05, T > 5.03). Control groups within the fully crossed designs did not exhibit any statistically significant changes in behavior or signal intensity changes. Regional patterns of modulated activity include the retrosplenial, piriform, insular, entorhinal, cingulate, visual and auditory cortices, posterior fields of the hippocampus, and in particular the dentate gyrus. Such areas are consistent with biochemical correlates of morphine withdrawal and time profiles derived from our behavioral observations (P < 0.02). A notable lack of signal intensity changes in a number of subcortical areas suggests a possible confound associated with fMRI under anesthesia. This paper reports the first whole brain fMRI examination of an animal model of drug withdrawal, we believe there is considerable scope for extrapolation of our methods to a multitude of pharmacological applicationsmost notably in conjunction with other techniques in the development of potential therapeutic agents for drug dependence. © 2002 Elsevier Science (USA).
Language: English
Document Type: Research article
DOI: http://dx.doi.org/10.1006/nimg.2002.1251
Affiliations: 1: Department of Neurology, Kings College London, 4 Windsor Walk, London, SE5 8BB, United Kingdom 2: The MRI Unit, The National Society for Epilepsy, Chalfont St. Peter, Buckinghamshire, SL9 0RJ, United Kingdom 3: Section of Behavioural Pharmacology, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, United Kingdom
Publication date: 2002-10-01
- In this: publication
- By this: publisher
- In this Subject: Neurology & Psychiatry
- By this author: Lowe A.S. ; Williams S.C.R. ; Symms M.R. ; Stolerman I.P. ; Shoaib M.

Shopping cart
Get Permissions